Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209,100 | 249,200 | 271,000 | 152,800 | 105,600 |
| Receivables | 84,200 | 149,500 | 79,800 | 203,700 | 154,500 |
| Inventories | 343,400 | 356,300 | 338,600 | 314,000 | 311,700 |
| Other current assets | 0 | 6,300 | 6,100 | 6,100 | 0 |
| TOTAL | $662,500 | $786,900 | $719,500 | $706,800 | $598,700 |
| Non-Current Assets | |||||
| PPE Net | 205,400 | 209,800 | 216,100 | 221,000 | 270,600 |
| Intangibles | 436,500 | 452,700 | 469,000 | 485,200 | 501,500 |
| Other Non-Current Assets | 14,200 | 11,600 | 12,500 | 13,100 | 18,900 |
| TOTAL | $656,100 | $674,100 | $697,600 | $719,300 | $791,000 |
| Total Assets | $1,318,600 | $1,461,000 | $1,417,100 | $1,426,100 | $1,389,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 55,600 | 57,400 | 63,700 | 58,100 | 60,900 |
| Accrued Expenses | 54,000 | 50,500 | 45,100 | 37,900 | 73,800 |
| Other current liabilities | 15,800 | 28,600 | 18,300 | 15,900 | 21,900 |
| TOTAL | $132,200 | $136,500 | $127,100 | $111,900 | $162,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 572,100 | 663,100 | 667,800 | 665,700 | 663,700 |
| Other Non-Current Liabilities | 53,900 | 42,600 | 39,500 | 35,400 | 39,100 |
| TOTAL | $663,800 | $742,000 | $753,800 | $761,500 | $744,500 |
| Total Liabilities | $796,000 | $878,500 | $880,900 | $873,400 | $906,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,771 | 52,520 | 53,351 | 54,278 | 54,337 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -159,800 | -105,200 | -156,400 | -144,400 | -212,400 |
| Other shareholders' equity | -7,100 | -7,000 | -7,700 | -5,800 | -4,900 |
| TOTAL | $522,600 | $582,500 | $536,200 | $552,700 | $482,800 |
| Total Liabilities And Equity | $1,318,600 | $1,461,000 | $1,417,100 | $1,426,100 | $1,389,700 |